Immune Checkpoint Inhibitors in the Treatment of Stage III NSCLC: A Primer for Managed Care Pharmacy

Watch an on-demand Webcast and download slidesets from our live symposia at AMCP 2018 and AMCP Nexus 2018 where our pharmacy and oncology experts reviewed the rationale for checkpoint inhibitor therapy in unresectable stage III NSCLC how to optimally integrate checkpoint inhibitors into this setting and strategies for identifying and managing immune-related adverse events.

Share

Program Content

Activities

ICI in Stage III NSCLC: Rationale
Evaluating the Role of Immune Checkpoint Inhibitors in Unresectable Stage III NSCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: April 27, 2018

Expires: April 26, 2019

ICI in Stage III NSCLC: Efficacy
Optimal Integration of Checkpoint Inhibitors Into the Management of Unresectable Stage III NSCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: April 27, 2018

Expires: April 26, 2019

ICI in Stage III NSCLC: irAE Management
Strategies to Identify and Manage Immune-Mediated Adverse Events With Immune Checkpoint Inhibitors
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: April 27, 2018

Expires: April 26, 2019

Activities

Pharmacy: ICI for Stage III NSCLC
Immune Checkpoint Inhibitors in the Treatment of Stage III NSCLC: A Primer for Managed Care Pharmacy
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: June 12, 2018

Expires: June 11, 2019

Faculty

cover img faculity

Mark M. Awad, MD, PhD

Assistant Professor
Dana-Farber Cancer Institute
Harvard Medical School
Boston, Massachusetts

cover img faculity

Sandra Cuellar, PharmD, BCOP, FHOPA, FASHP

Clinical Oncology Pharmacist, UI Health
Clinical Associate Professor
University of Illinois at Chicago College of Pharmacy
Chicago, Illinois

cover img faculity

Ali McBride, PharmD, MS, BCOP, FAzPA

Clinical Coordinator
Department of Pharmacy
The University of Arizona Cancer Center
Tucson, Arizona

cover img faculity

Tarek Mekhail, MD, MSc, FRCSI, FRCSEd

Medical Director, Thoracic Cancer Program
Florida Hospital Medical Group
Orlando, Florida

Provided by

ProCE Banner

Supporters

This activity is supported by an educational grant from

AstraZeneca